154 related articles for article (PubMed ID: 15040808)
1. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
[TBL] [Abstract][Full Text] [Related]
2. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
[TBL] [Abstract][Full Text] [Related]
3. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2.
Almaguer-Mederos LE; Almaguer-Gotay D; Aguilera-Rodríguez R; González-Zaldívar Y; Cuello-Almarales D; Laffita-Mesa J; Vázquez-Mojena Y; Zayas-Feria P; Rodríguez-Labrada R; Velázquez-Pérez L; MacLeod P
J Neurol Sci; 2017 Jan; 372():324-328. PubMed ID: 28017238
[TBL] [Abstract][Full Text] [Related]
4. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
5. [Study of the association of genotype and phenotype features of the pathogenesis of Huntington's chorea].
Hryshchenko NV; Kucherenko AM; Patskun EI; Livshyts' LA
Tsitol Genet; 2009; 43(3):42-7. PubMed ID: 19938636
[TBL] [Abstract][Full Text] [Related]
6. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
7. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT
Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase omega-2 polymorphism Asn142Asp modifies the risk of age-related cataract in smokers and subjects exposed to ultraviolet irradiation.
Stamenkovic M; Radic T; Stefanovic I; Coric V; Sencanic I; Pljesa-Ercegovac M; Matic M; Jaksic V; Simic T; Savic-Radojevic A
Clin Exp Ophthalmol; 2014 Apr; 42(3):277-83. PubMed ID: 23927022
[TBL] [Abstract][Full Text] [Related]
9. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT
J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of the impact of lifestyle on age at onset of Huntington disease.
Trembath MK; Horton ZA; Tippett L; Hogg V; Collins VR; Churchyard A; Velakoulis D; Roxburgh R; Delatycki MB
Mov Disord; 2010 Jul; 25(10):1444-50. PubMed ID: 20629137
[TBL] [Abstract][Full Text] [Related]
11. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
[TBL] [Abstract][Full Text] [Related]
12. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
[TBL] [Abstract][Full Text] [Related]
13. Chorea Huntington: a rare case with childhood onset.
Gencik M; Hammans C; Strehl H; Wagner N; Epplen JT
Neuropediatrics; 2002 Apr; 33(2):90-2. PubMed ID: 12075490
[TBL] [Abstract][Full Text] [Related]
14. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
Squitieri F; Frati L; Ciarmiello A; Lastoria S; Quarrell O
Mech Ageing Dev; 2006 Feb; 127(2):208-12. PubMed ID: 16274727
[TBL] [Abstract][Full Text] [Related]
15. Intergeneration CAG expansion and contraction in a Chinese HD family.
Tang Y; Wang Y; Yang P; Liu Y; Wang B; Podolsky R; McIndoe R; Wang CY
Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):242-4. PubMed ID: 16526033
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of mitochondrial function in Huntington's disease muscle.
Turner C; Cooper JM; Schapira AH
Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India.
Pramanik S; Basu P; Gangopadhaya PK; Sinha KK; Jha DK; Sinha S; Das SK; Maity BK; Mukherjee SC; Roychoudhuri S; Majumder PP; Bhattacharyya NP
Eur J Hum Genet; 2000 Sep; 8(9):678-82. PubMed ID: 10980573
[TBL] [Abstract][Full Text] [Related]
19. Huntington's disease as caused by 34 CAG repeats.
Andrich J; Arning L; Wieczorek S; Kraus PH; Gold R; Saft C
Mov Disord; 2008 Apr; 23(6):879-81. PubMed ID: 18307262
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.
Saft C; Andrich JE; Brune N; Gencik M; Kraus PH; Przuntek H; Epplen JT
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1692-6. PubMed ID: 15548484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]